Akèy › Kansè Vezik ki pa envazif miskilè › New York › Syracuse
Etid klinik pou Kansè Vezik ki pa envazif miskilè nan Syracuse, NY
8 etid pou Kansè Vezik ki pa envazif miskilè ap chèche patisipan nan sit nan ak bò kote Syracuse (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
Efficacy and Safety of TYRA-300 in Participants With FGFR3 Altered Low Grade, Intermediate Risk Non-Muscle Invasive Bladder Cancer
Ap rekriteFaz 2
- Associated Medical Professionals of NY, Syracuse
- State University of New York (SUNY) Upstate Medical University, Syracuse
A Study to Evaluate TAR-210 Versus Intravesical Chemotherapy Treatment in Participants With High Risk Non-Muscle-Invasive Bladder Cancer
Ap rekriteFaz 3
- Associated Medical Professionals, Syracuse
A Study to Learn About the Study Medicine PF-08052667 in People With Bladder Cancer
Ap rekriteFaz 1
- Upstate Specialty Services at Harrison Center, Syracuse
- SUNY Upstate Medical University, Syracuse
- SUNY Upstate Medical University-Community Campus, Syracuse
A Study to Assess Real-World Use and Outcomes of TAR-200 for Participants With Non-Muscle Invasive Bladder Cancer (NMIBC) in the United States
Ap rekriteEtid obsèvasyon
- SUNY Upstate Med Univ, Syracuse
Safety and Efficacy Study of Intravesical Instillation of TARA-002 in Adults With High-grade Non-muscle Invasive Bladder Cancer
Ap rekriteFaz 2
- Associated Medical Professionals of NY, PLLC, Syracuse
LEGEND Study: EG-70 in NMIBC Patients BCG-Unresponsive and High-Risk NMIBC Incompletely Treated With BCG or BCG-Naïve
Ap rekriteFaz 1/2
- Associated Medical Professionals of NY,, Syracuse
ResQ133A-NMIBC: Intravesical Recombinant Mycobacterium (rMBCG) in Participants With NMIBC Eligible to Receive Intravesical Tice BCG
Ap rekriteFaz 1/2
- SUNY Upstate Medical University, Syracuse
Intravesical Photodynamic Therapy ("PDT") in BCG-Unresponsive/Intolerant Non-Muscle Invasive Bladder Cancer ("NMIBC") Patients
Ap rekriteFaz 2
- Site 02-015 - Associated Medical Professionals of New York, Syracuse
Etid Kansè Vezik ki pa envazif miskilè nan lòt vil
- Columbus, OH10 etid
- Dallas, TX10 etid
- New York City, NY10 etid
- Myrtle Beach, SC9 etid
- Edison, NJ9 etid
- Baltimore, MD8 etid
- Nashville, TN8 etid
- Houston, TX7 etid
- Indianapolis, IN7 etid
- Philadelphia, PA7 etid
- Birmingham, AL7 etid
- Atlanta, GA7 etid
Lòt etid nan Syracuse
- Kansè Poumon ki pa ti selil15 etid
- Kansè (tout kalite)9 etid
- Kansè pwostat9 etid
- Kansè ovè7 etid
- Kansè Endomèt7 etid
- Obèsite6 etid
- Kansè poumon6 etid
- Kansè kolorektal5 etid
- Degeneresans makile5 etid
- Leksemi mieloïd egi5 etid
- Dyabèt Tip 25 etid
- Lupus5 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.